Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: TEVA PHARMACEUTICALS USA, INC.
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-09-12 to 2023-09-19
Current total value of award: $152696.88
Description: 8510134901!ADENOVIRUS TYPE 4 A